Skip to main content
Top

Cancer Causes & Control

Issue 8/2005

Content (9 Articles)

Zinc and Prostate Cancer: A Critical Scientific, Medical, and Public Interest Issue (United States)

Leslie C. Costello, Renty B. Franklin, Pei Feng, Ming Tan, Omar Bagasra

Breast Cancer and Dietary Factors in Taiwanese Women

Marion M. Lee, Ilona Yuan Hui Chang, Cheng Fang Horng, Jeffrey S. Chang, Skye Hongiun Cheng, Andrew Huang

Occupational Exposures and Haematological Malignancies: Overview on Human Recent Data

Alexis Descatha, Arash Jenabian, Françoise Conso, Jacques Ameille

Anthropometric Measurements and Epithelial Ovarian Cancer Risk in African–American and White women

Cathrine Hoyo, Andrew Berchuck, Susan Halabi, Rex C. Bentley, Patricia Moorman, Brian Calingaert, Joellen M. Schildkraut

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine